Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
Apr 16, 2020
Document Date
Apr 14, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
DAVIS JOHN C. JR